Cavan S Reilly
Overview
Explore the profile of Cavan S Reilly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
2073
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pragman A, Hodgson S, Wu T, Zank A, Kelly R, Reilly C, et al.
Respir Res
. 2024 Mar;
25(1):130.
PMID: 38500160
Rationale: The lung microbiome is an inflammatory stimulus whose role in the development of lung malignancies is incompletely understood. We hypothesized that the lung microbiome associates with multiple clinical factors,...
2.
Pragman A, Hodgson S, Wu T, Zank A, Reilly C, Wendt C
ERJ Open Res
. 2024 Feb;
10(1).
PMID: 38333651
Background: The lung microbiome is an inflammatory stimulus whose role in COPD pathogenesis is incompletely understood. We hypothesised that the frequent exacerbator phenotype is associated with decreased α-diversity and increased...
3.
Reilly C, Borges A, Baker J, Safo S, Sharma S, Polizzotto M, et al.
J Infect Dis
. 2022 Dec;
227(8):951-960.
PMID: 36580481
Background: There is an incompletely understood increased risk for cardiovascular disease (CVD) among people with HIV (PWH). We investigated if a collection of biomarkers were associated with CVD among PWH....
4.
Barkauskas C, Mylonakis E, Poulakou G, Young B, Vock D, Siegel L, et al.
Ann Intern Med
. 2022 Aug;
175(9):1266-1274.
PMID: 35939810
Background: Ensovibep (MP0420) is a designed ankyrin repeat protein, a novel class of engineered proteins, under investigation as a treatment of SARS-CoV-2 infection. Objective: To investigate if ensovibep, in addition...
5.
Pragman A, Fieberg A, Reilly C, Wendt C
BMJ Open
. 2021 Dec;
11(12):e050271.
PMID: 34903538
Objectives: Determine the effect of twice-daily chlorhexidine oral rinses on oral and lung microbiota biomass and respiratory symptoms. Setting: Single centre. Participants: Participants were aged 40-85 with chronic obstructive pulmonary...
6.
Johnstone K, Wei Y, Bittner-Eddy P, Vreeman G, Stone I, Clayton J, et al.
Infect Immun
. 2021 Jun;
89(10):e0012221.
PMID: 34097505
Upregulated in inflammation, calprotectin (complexed S100A8 and S100A9; S100A8/A9) functions as an innate immune effector molecule, promoting inflammation, and also as an antimicrobial protein. We hypothesized that antimicrobial S100A8/A9 would...
7.
Bozman C, Fallah M, Sneller M, Freeman C, Fakoli 3rd L, Shobayo B, et al.
Emerg Infect Dis
. 2021 Mar;
27(4):1239-1241.
PMID: 33755000
Ebola virus RNA can reside for months or years in semen of survivors of Ebola virus disease and is probably associated with increased risk for cryptic sexual transmission of the...
8.
Kieh M, Browne S, Grandits G, Blie J, Doe-Anderson J, Hoover M, et al.
Afr J Lab Med
. 2020 Dec;
9(1):1080.
PMID: 33354527
Background: As more research is conducted in Liberia, there is a need for laboratory reference limits for common chemistry and haematology values based on a healthy population. Reference limits from...
9.
Pragman A, Knutson K, Gould T, Hodgson S, Isaacson R, Reilly C, et al.
PLoS One
. 2019 Jul;
14(7):e0219962.
PMID: 31335912
Background: Chronic obstructive pulmonary disease (COPD) is an inflammatory lung disorder associated with lung microbiome dysbiosis. Although the upper airway microbiome is the source of the lung microbiome, the relationships...
10.
Pragman A, Knutson K, Gould T, Isaacson R, Reilly C, Wendt C
Respir Res
. 2019 Jun;
20(1):114.
PMID: 31174538
Background: Chronic obstructive pulmonary disease (COPD) frequent exacerbators (FE) suffer increased morbidity and mortality compared to infrequent exacerbators (IE). The association between the oral and sputum microbiota and exacerbation phenotype...